Markets

Market Nav

CASH FLOW

You can view the cash flow for the last 5 years.
GlaxoSmithKline Pharmaceuticals Ltd.
( in Crs.)

ParticularsMar 25Mar 24Mar 23Mar 22Mar 21
Months1212121212
Source Of Info (AR = Annual Report, PR = Press Release)ARARARARAR
FaceValue10.0010.0010.0010.0010.00
      
Net Profit/Loss Before Extraordinary Items And Tax1255.19959.80841.492475.65723.10
      
Net CashFlow From Operating Activities1289.90582.02484.23810.75577.93
Net Cash Used In Investing Activities-45.808.71807.85-405.51418.59
Net Cash Used From Financing Activities-769.42-561.50-1543.32-524.24-696.14
      
Net Inc/Dec In Cash And Cash Equivalents474.6829.23-251.25-119.00300.38
Cash And Cash Equivalents Begin of Year64.1734.94286.19405.19104.81
Cash And Cash Equivalents End Of Year538.8564.1734.94286.19405.19
ParticularsMar 25
Months12
Source Of Info (AR = Annual Report, PR = Press Release)AR
FaceValue10.00
  
Net Profit/Loss Before Extraordinary Items And Tax1255.19
Net CashFlow From Operating Activities1289.90
Net Cash Used In Investing Activities-45.80
Net Cash Used From Financing Activities-769.42
Net Inc/Dec In Cash And Cash Equivalents474.68
Cash And Cash Equivalents Begin of Year64.17
Cash And Cash Equivalents End Of Year538.85